Alao, Renna Jane L.
HRN: 26-15-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2025
CEFUROXIME 750MG (VIAL)
05/22/2025
05/29/2025
IV
360mg
Q8H
ATP
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes